Institutional investors purchased a net $16.2 million shares of AGN during the quarter ended March 2017 and now own 87.42% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VERITAS ASSET MANAGEMENT LLP Bought 3.2 Million shares of Allergan
JENNISON ASSOCIATES LLC Bought 1.6 Million shares of Allergan
GOLDMAN SACHS & CO. LLC (PRIVATE... Bought 1.3 Million shares of Allergan